We aim to achieve the first enrollment in any study we undertake (with the goal of first enrollment within six weeks of receiving a final protocol), and our sites are among the highest for enrollment. Our ability to recruit patients from our extensive network of hospitals, community clinics, patient organizations, and outreach channels allows us to tackle a broad range of therapeutic areas in both acute and chronic care medicine. Our group of Principal Investigator's meet weekly to evaluate new protocols in terms of technical and patient feasibility. We welcome the opportunity to explore your research needs!
"As longtime collaborators, eStudySite has been a valued partner providing their clinical insights from the protocol planning stages through study execution for phase 2 and phase 3 registration studies. They consistently provided high quality data and met or exceeded enrollment targets from the early stage clinical trials through the approval of NUZYRA." - Chief Executive Officer, Paratek Pharmaceuticals
"eStudySite participated in our recent ABSSSI Study. They enrolled the study in half the time while ensuring the collection of high quality data and patient compliance. " - Vice President Clinical Operations, Pharma Sponsor